Patrícia Silva is Research Assistant and Invited Auxiliar Professor of Morfologia e Funções do Corpo Humano at the Universitary Institute of Health Sciences (IUCS) of CESPU. She graduated in Pathological, Cytological and Thanatological Anatomy (CESPU) in 2008 and completed a Master in Molecular Biology Techniques and Cytomics in Health Science (CESPU) in 2011. From 2013 to 2017 she was devoted to her PhD in Biomedical Sciences, from the Departamento de Ciências Biomédicas e Medicina da Universidade do Algarve, where she explored the function, regulation and therapeutic implications of the Spindle assembly Checkpoint (SAC) mechanism (FEBS Lett. 2014 Aug 25;588(17):3265-73; FEBS Lett. 2015 Nov 30;589(23):3588-94; Cancer Lett. 2017 May 28;394:33-42). The PhD work were performed at the Centre for Biomedical Research (CBMR, Ualg) in collaboration with CESPU. Currently, her research interest focuses on the clinical relevance of mitosis regulation and in development of strategies to kill cancer cells or to increase their sensitivity to currently anti-mitotic agents (Oral Dis. 2019 Jul;25(5):1291-1301; Pharmaceutics. 2020 Dec 6;12(12):1186; Sci Rep. 2021 Feb 18;11(1):4139; Pharmaceutics. 2021 Jul 2;13(7):1011.; Curr Cancer Drug Targets. 2021;21(5):401-415; Pharmaceutics 14 6 (2022): 1209.). She published 31 articles in international peer reviewed (ISI) journals, most in Q1, was author/co-author of 27 invited/selected talks in national and international meetings, was partner of 22 projects with competitive funding (FCT, Norte2020, CESPU), and she has co-supervised 20 MSc and graduated students and 2 PhD students.
Patrícia Silva is Research Assistant and Invited Auxiliar Professor of Morfologia e Funções do Corpo Humano at the Universitary Institute of Health Sciences (IUCS) of CESPU. She graduated in Pathological, Cytological and Thanatological Anatomy (CESPU) in 2008 and completed a Master in Molecular Biology Techniques and Cytomics in Health Science (CESPU) in 2011. From 2013 to 2017 she was devoted to her PhD in Biomedical Sciences, from the Departamento de Ciências Biomédicas e Medicina da Universidade do Algarve, where she explored the function, regulation and therapeutic implications of the Spindle assembly Checkpoint (SAC) mechanism (FEBS Lett. 2014 Aug 25;588(17):3265-73; FEBS Lett. 2015 Nov 30;589(23):3588-94; Cancer Lett. 2017 May 28;394:33-42). The PhD work were performed at the Centre for Biomedical Research (CBMR, Ualg) in collaboration with CESPU. Currently, her research interest focuses on the clinical relevance of mitosis regulation and in development of strategies to kill cancer cells or to increase their sensitivity to currently anti-mitotic agents (Oral Dis. 2019 Jul;25(5):1291-1301; Pharmaceutics. 2020 Dec 6;12(12):1186; Sci Rep. 2021 Feb 18;11(1):4139; Pharmaceutics. 2021 Jul 2;13(7):1011.; Curr Cancer Drug Targets. 2021;21(5):401-415; Pharmaceutics 14 6 (2022): 1209.). She published 31 articles in international peer reviewed (ISI) journals, most in Q1, was author/co-author of 27 invited/selected talks in national and international meetings, was partner of 22 projects with competitive funding (FCT, Norte2020, CESPU), and she has co-supervised 20 MSc and graduated students and 2 PhD students.
Translational Toxicology Lab Member